• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强 MRI 列线图模型鉴别肝胆期呈等或高信号的肝细胞肝癌和局灶性结节增生。

Gd-EOB-DTPA enhanced MRI nomogram model to differentiate hepatocellular carcinoma and focal nodular hyperplasia both showing iso- or hyperintensity in the hepatobiliary phase.

机构信息

Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.

School of Radiation Medicine and Protection, Soochow University, Suzhou, China.

出版信息

BMC Med Imaging. 2024 Aug 12;24(1):211. doi: 10.1186/s12880-024-01382-6.

DOI:10.1186/s12880-024-01382-6
PMID:39134943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320848/
Abstract

BACKGROUND

To develop and validate a nomogram model based on Gd-EOB-DTPA enhanced MRI for differentiation between hepatocellular carcinoma (HCC) and focal nodular hyperplasia (FNH) showing iso- or hyperintensity in the hepatobiliary phase (HBP).

METHODS

A total of 75 patients with 49 HCCs and 26 FNHs randomly divided into a training cohort (n = 52: 34 HCC; 18 FNH) and an internal validation cohort (n = 23: 15 HCC; 8 FNH). A total of 37 patients (n = 37: 25 HCC; 12 FNH) acted as an external test cohort. The clinical and imaging characteristics between HCC and FNH groups in the training cohort were compared. The statistically significant parameters were included into the FAE software, and a multivariate logistic regression classifier was used to identify independent predictors and establish a nomogram model. Receiver operating characteristic (ROC) curves were used to evaluate the prediction ability of the model, while the calibration and decision curves were used for model validation. Subanalysis was used to compare qualitative and quantitative characteristics of patients with chronic hepatitis and cirrhosis between the HCC and FNH groups.

RESULTS

In the training cohort, gender, age, enhancement rate in the arterial phase (AP), focal defects in uptake were significant predictors for HCC showing iso- or hyperintensity in the HBP. In the training cohort, area under the curve (AUC), sensitivity and specificity of the nomogram model were 0.989(95%CI: 0.967-1.000), 97.1% and 94.4%. In the internal validation cohort, the above three indicators were 0.917(95%CI: 0.782-1.000), 93.3% and 87.5%. In the external test cohort, the above three indicators were 0.960(95%CI: 0.905-1.000), 84.0% and 100.0%. The results of subanalysis showed that age was the independent predictor in the patients with chronic hepatitis and cirrhosis between HCC and FNH groups.

CONCLUSIONS

Gd-EOB-DTPA enhanced MRI nomogram model may be useful for discriminating HCC and FNH showing iso- or hyperintensity in the HBP before surgery.

摘要

背景

为了建立并验证一个基于钆塞酸二钠增强 MRI 肝胆期(HBP)等/高信号的肝细胞癌(HCC)和局灶性结节增生(FNH)鉴别诊断的列线图模型。

方法

共纳入 75 例患者,其中 49 例 HCC 和 26 例 FNH,随机分为训练队列(n=52:34 例 HCC;18 例 FNH)和内部验证队列(n=23:15 例 HCC;8 例 FNH)。另外 37 例(n=37:25 例 HCC;12 例 FNH)为外部测试队列。比较训练队列中 HCC 和 FNH 组的临床和影像学特征。将统计学上有意义的参数输入到 FAE 软件中,然后使用多变量逻辑回归分类器识别独立预测因子并建立列线图模型。通过受试者工作特征(ROC)曲线评估模型的预测能力,同时通过校准和决策曲线进行模型验证。亚组分析比较慢性肝炎和肝硬化患者 HCC 和 FNH 组的定性和定量特征。

结果

在训练队列中,性别、年龄、动脉期(AP)强化率、摄取的局灶性缺损是 HCC 在 HBP 等/高信号的显著预测因子。在训练队列中,列线图模型的曲线下面积(AUC)、敏感性和特异性分别为 0.989(95%CI:0.967-1.000)、97.1%和 94.4%。在内部验证队列中,上述三项指标分别为 0.917(95%CI:0.782-1.000)、93.3%和 87.5%。在外部测试队列中,上述三项指标分别为 0.960(95%CI:0.905-1.000)、84.0%和 100.0%。亚组分析结果显示,年龄是慢性肝炎和肝硬化患者 HCC 和 FNH 组的独立预测因子。

结论

钆塞酸二钠增强 MRI 列线图模型可用于术前鉴别诊断 HBP 等/高信号的 HCC 和 FNH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/ca020c86927e/12880_2024_1382_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/c7e05a153a2a/12880_2024_1382_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/e7ea85e74605/12880_2024_1382_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/0f4c03cb11d6/12880_2024_1382_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/4938a21c583e/12880_2024_1382_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/403680118c98/12880_2024_1382_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/ca020c86927e/12880_2024_1382_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/c7e05a153a2a/12880_2024_1382_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/e7ea85e74605/12880_2024_1382_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/0f4c03cb11d6/12880_2024_1382_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/4938a21c583e/12880_2024_1382_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/403680118c98/12880_2024_1382_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b409/11320848/ca020c86927e/12880_2024_1382_Fig6_HTML.jpg

相似文献

1
Gd-EOB-DTPA enhanced MRI nomogram model to differentiate hepatocellular carcinoma and focal nodular hyperplasia both showing iso- or hyperintensity in the hepatobiliary phase.钆塞酸二钠增强 MRI 列线图模型鉴别肝胆期呈等或高信号的肝细胞肝癌和局灶性结节增生。
BMC Med Imaging. 2024 Aug 12;24(1):211. doi: 10.1186/s12880-024-01382-6.
2
[The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].[基于钆塞酸二钠增强MRI的影像组学在肝胆期等或高信号肝癌与肝局灶性结节增生鉴别诊断中的应用价值]
Zhonghua Yi Xue Za Zhi. 2023 Sep 5;103(33):2599-2606. doi: 10.3760/cma.j.cn112137-20230117-00095.
3
Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.CT 和 MRI 鉴别肝胆期增强 MRI 显示高信号的肝细胞癌与局灶性结节增生。
AJR Am J Roentgenol. 2018 Aug;211(2):347-357. doi: 10.2214/AJR.17.19341. Epub 2018 Apr 30.
4
HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.增强型肝细胞腺瘤及其在钆塞酸增强 MRI 中的与 FNH 鉴别
BMC Med Imaging. 2021 Feb 15;21(1):28. doi: 10.1186/s12880-021-00552-0.
5
Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.钆塞酸二钠增强磁共振成像中的廓清表现:肝胆期呈反向摄取的肝细胞癌与局灶性结节样增生样结节之间的鉴别特征
J Magn Reson Imaging. 2017 Jun;45(6):1599-1608. doi: 10.1002/jmri.25493. Epub 2016 Oct 11.
6
The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.钆塞酸二钠增强磁共振成像对肝脏局灶性结节增生的诊断价值:一项系统评价与Meta分析
Eur Radiol. 2015 Apr;25(4):950-60. doi: 10.1007/s00330-014-3499-9. Epub 2014 Dec 24.
7
OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.OATPB1/B3 和 MRP3 在肝细胞腺瘤中的表达可预测 Gd-EOB-DTPA 摄取,与恶性风险相关。
Liver Int. 2019 Jan;39(1):158-167. doi: 10.1111/liv.13964. Epub 2018 Oct 8.
8
Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.钆塞酸增强 MRI 肝胆期形态增强模式对鉴别局灶性结节增生与肝细胞腺瘤的诊断价值。
Radiol Med. 2021 Nov;126(11):1379-1387. doi: 10.1007/s11547-021-01403-2. Epub 2021 Jul 21.
9
[Differentiation between hyperintense hepatocellular carcinoma and focal nodular hyperplasia in hepatobiliary phase with multimodal parameters of magnetic resonance imaging].[利用磁共振成像多模态参数在肝胆期鉴别高强度肝细胞癌与局灶性结节性增生]
Zhonghua Gan Zang Bing Za Zhi. 2022 Oct 20;30(10):1069-1073. doi: 10.3760/cma.j.cn501113-20200803-00432.
10
Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.患者内比较 Gd-BOPTA 和 Gd-EOB-DTPA 的肝胆期在肝细胞腺瘤与局灶性结节增生鉴别诊断中的作用。
J Magn Reson Imaging. 2019 Mar;49(3):700-710. doi: 10.1002/jmri.26227. Epub 2018 Sep 25.

本文引用的文献

1
Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma.列线图基于 Lasso-Cox 回归建立,用于预测早期肝细胞癌患者的复发情况。
Front Immunol. 2022 Nov 23;13:1019638. doi: 10.3389/fimmu.2022.1019638. eCollection 2022.
2
The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt.肝细胞癌的临床病理和预后因素:埃及一家三级中心的 10 年经验。
World J Surg Oncol. 2022 Sep 19;20(1):298. doi: 10.1186/s12957-022-02764-2.
3
Focal Nodular Hyperplasia and Focal Nodular Hyperplasia-like Lesions.
局灶性结节性增生和局灶性结节性增生样病变。
Radiographics. 2022 Jul-Aug;42(4):1043-1061. doi: 10.1148/rg.210156. Epub 2022 Jun 10.
4
Changing epidemiology of hepatocellular carcinoma in Asia.亚洲肝细胞癌的流行病学变化。
Liver Int. 2022 Aug;42(9):2029-2041. doi: 10.1111/liv.15251. Epub 2022 Apr 3.
5
Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging.利用计算机断层扫描光谱成像鉴别肝细胞癌与肝血管瘤及局灶性结节性增生
J Clin Transl Hepatol. 2021 Jun 28;9(3):315-323. doi: 10.14218/JCTH.2020.00173. Epub 2021 Mar 31.
6
An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver.基于磁共振的放射组学模型在非肝硬化肝脏中鉴别肝细胞癌和局灶性结节增生
World J Surg Oncol. 2021 Jun 21;19(1):181. doi: 10.1186/s12957-021-02266-7.
7
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.基于 MRI 影像组学的Nomogram 模型预测 TACE 治疗 HCC 的肿瘤应答情况。
Eur Radiol. 2021 Oct;31(10):7500-7511. doi: 10.1007/s00330-021-07910-0. Epub 2021 Apr 16.
8
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.肝细胞癌(HCC):流行病学、病因学和分子分类。
Adv Cancer Res. 2021;149:1-61. doi: 10.1016/bs.acr.2020.10.001. Epub 2020 Nov 28.
9
Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.肝胆期肝脏病变呈高信号的谱系:基于临床背景的探讨方法
Insights Imaging. 2021 Jan 12;12(1):8. doi: 10.1186/s13244-020-00928-w.
10
Benign Liver Tumors.良性肝脏肿瘤
Visc Med. 2020 Aug;36(4):292-303. doi: 10.1159/000509145. Epub 2020 Aug 4.